FDA Inspection 1207917 — American National Red Cross

American National Red Cross — FEI 1527569

The FDA completed an inspection of American National Red Cross on May 30, 2023 in Newark, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 30, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Newark, OH (United States)